Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice

Transplantation
S QianA W Thomson

Abstract

Cellular interleukin-10 (cIL-10) has been shown to inhibit cytokine production by T helper type 1 (Th1) cells by blocking antigen presenting cell function. This activity has suggested that IL-10 might be useful in the treatment of transplant rejection. Stimulatory effects of IL-10 however, have also been observed both on T and B cell differentiation. In this study, we examined the influence of recombinant (r) mouse (m) IL-10 on heterotopic vascularized heart allograft survival in the B10(H2b)-->C3H(H2k) strain combination that crosses both major histocompatibility complex (MHC) and non-MHC-histocompatibility antigen (non-MHC-HA) barriers. The influence of IL-10 was also examined in the B10.BR (H2k)--> C3H combination with disparity at only non-MHC-HA loci. Postoperative intraperitoneal administration of IL-10 (100 microg/d, days 0-6) significantly accelerated heart graft rejection both in the B10-->C3H (mean survival time [MST] 7.8+/-0.2 days; control MST 10.6+/-0.6 days; P<0.05) and the B10.BR-->C3H combination (MST 14.3+/-0.5 days; control MST 77.7+/-14.4 days). Ex vivo IL-10 perfusion of donor hearts for either 15 min or 2 hr did not affect subsequent graft survival. Immunologic monitoring of transplanted mice revealed that ...Continue Reading

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·F RoussetJ Banchereau
Mar 1, 1992·European Journal of Immunology·A O'GarraM Howard
Dec 1, 1991·The Journal of Experimental Medicine·C BogdanC Nathan
Feb 1, 1991·The Journal of Experimental Medicine·L Thompson-SnipesD M Rennick
Dec 1, 1989·The Journal of Experimental Medicine·D F FiorentinoT R Mosmann
Apr 1, 1994·European Journal of Immunology·F WillemsM Goldman
Aug 1, 1994·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·M A SchwarzL M Sullivan
Apr 1, 1994·The Journal of Experimental Medicine·A H EnkJ Knop
Apr 1, 1994·European Journal of Immunology·J Péguet-NavarroD Schmitt
Dec 1, 1993·International Immunology·K TagaG Tosato

❮ Previous
Next ❯

Citations

Feb 10, 2000·Springer Seminars in Immunopathology·M R ShurinM T Lotze
Jan 15, 2009·International Urology and Nephrology·Mohsen NafarBehzad Eniollahi
Jan 30, 2004·Cytokine & Growth Factor Reviews·Simone MocellinMario Lise
Jul 25, 2003·The Journal of Thoracic and Cardiovascular Surgery·Michael P FischbeinAbbas Ardehali
Mar 27, 2001·Transplantation Proceedings·A DosanjhB Wan
Mar 27, 2001·Transplantation Proceedings·H JiangM Kobayashi
Nov 15, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Yoo Sun HongLuyi Sen
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·O Le MoineJ Devière
Jan 17, 2002·Transplantation·Steffen PelzlCaner Süsal
Jul 17, 1998·Transplant International : Official Journal of the European Society for Organ Transplantation·R WeimerG Opelz
Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra
Nov 11, 2008·American Journal of Respiratory and Critical Care Medicine·Guicheng ZhangPatrick G Holt
Oct 14, 2011·Journal of Translational Medicine·Tara L SpiveyDavide Bedognetti
Dec 20, 1999·Japanese Circulation Journal·Y FurukawaS Sasayama
Jan 29, 2011·Seminars in Immunopathology·Takeshi NakajimaPatricia W Finn
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H LouisJ Devière
Sep 4, 2004·Clinical Transplantation·Arcangelo NoceraUmberto Valente

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Related Papers

Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]
Kristina Muñoz-Flores ThiagarajanVincent T Armenti
The Journal of Immunology : Official Journal of the American Association of Immunologists
David LissauerPaul A Moss
© 2022 Meta ULC. All rights reserved